NIH – Outcome Measures for Use in Treatment Trials of Individuals with Intellectual and Developmental Disabilities (R01)
Objetivo: This funding opportunity announcement (FOA) encourages applications from institutions/organizations that propose to develop informative outcome measures for use in clinical trials for individuals with intellectual and developmental disabilities (IDD). This FOA will address a significant need in the field, one that is especially apparent in efforts to develop pharmacological treatments for these populations. This FOA will focus ongoing clinical and translational research on a neglected area essential for therapy and pharmacological treatment development.
Inscrições: até 05 de fevereiro de 2018
Mais informações no site.